Terms: = Ovarian cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6 AND Diagnosis
280 results:
1. Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer.
Cheng Y; Li Q; Sun G; Li T; Zou Y; Ye H; Wang K; Shi J; Wang P
Sci Rep; 2024 Apr; 14(1):9757. PubMed ID: 38684875
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of serum CA125, he4 and CA724 and the risk of ovarian malignancy algorithm score in the diagnosis of high-grade serous ovarian cancer.
Hu D; Qian J; Yin F; Wei B; Wang J; Zhang H; Yang H
Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():170-175. PubMed ID: 38663180
[TBL] [Abstract] [Full Text] [Related]
3. Human epididymis protein 4: Analysis of national health and nutrition examination survey data.
Penick ER; Beltran TA; Choi YS; Wilson KL
Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():86-90. PubMed ID: 38598900
[TBL] [Abstract] [Full Text] [Related]
4. Bayesian and deep-learning models applied to the early detection of ovarian cancer using multiple longitudinal biomarkers.
Abrego L; Zaikin A; Marino IP; Krivonosov MI; Jacobs I; Menon U; Gentry-Maharaj A; Blyuss O
Cancer Med; 2024 Apr; 13(7):e7163. PubMed ID: 38597129
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of the Cutoff Point and Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio in Predicting ovarian cancer Compared to Pathological Findings.
Hosseini MS; Amiri F; Rezapour M; Ashraf Ganjoie T; Farzaneh F; Arab M; Talayeh M; Beheshti Rooy R; Hadi F
Asian Pac J Cancer Prev; 2024 Mar; 25(3):971-976. PubMed ID: 38546079
[TBL] [Abstract] [Full Text] [Related]
6. Evaluating the effectiveness of pre-operative diagnosis of ovarian cancer using minimally invasive liquid biopsies by combining serum human epididymis protein 4 and cell-free DNA in patients with an ovarian mass.
Gaillard DHK; Lof P; Sistermans EA; Mokveld T; Horlings HM; Mom CH; Reinders MJT; Amant F; van den Broek D; Wessels LFA; Lok CAR; ;
Int J Gynecol Cancer; 2024 May; 34(5):713-721. PubMed ID: 38388177
[TBL] [Abstract] [Full Text] [Related]
7. Noninvasive serum N-glycans associated with ovarian cancer diagnosis and precancerous lesion prediction.
Liu S; Tu C; Zhang H; Huang H; Liu Y; Wang Y; Cheng L; Liu BF; Ning K; Liu X
J Ovarian Res; 2024 Jan; 17(1):26. PubMed ID: 38281033
[TBL] [Abstract] [Full Text] [Related]
8. Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study.
Cai G; Huang F; Gao Y; Li X; Chi J; Xie J; Zhou L; Feng Y; Huang H; Deng T; Zhou Y; Zhang C; Luo X; Xie X; Gao Q; Zhen X; Liu J
Lancet Digit Health; 2024 Mar; 6(3):e176-e186. PubMed ID: 38212232
[TBL] [Abstract] [Full Text] [Related]
9. Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
Young Han C; Bedia JS; Yang WL; Hawley SJ; Bergan L; Hopper M; Celestino J; Guo J; Gornet TG; Soosaipillai A; Yang H; Doskocil SD; Lokshin AE; Handy BC; Diamandis EP; Moore RG; Lu KH; Lu Z; Anderson KS; Drescher CW; Skates SJ; Bast RC
Br J Cancer; 2024 Mar; 130(5):861-868. PubMed ID: 38195887
[TBL] [Abstract] [Full Text] [Related]
10. Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of CA125, he4, and C5a.
Shi H; Liu L; Deng X; Xing X; Zhang Y; Djouda Rebecca Y; Han L
J Ovarian Res; 2024 Jan; 17(1):4. PubMed ID: 38178252
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic value of CA125, he4, and systemic immune-inflammation index in the preoperative investigation of ovarian masses.
Song L; Qi J; Zhao J; Bai S; Wu Q; Xu R
Medicine (Baltimore); 2023 Sep; 102(37):e35240. PubMed ID: 37713838
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Significance of the TK1-Specific Activity in the Early Detection of ovarian cancer.
Osredkar J; Jagarlamudi KK; Cviič D; Škof E; Cvjetićanin B; Zore A; Lukanović D; Eriksson S; Meglič L
Oncology; 2024; 102(1):17-29. PubMed ID: 37673047
[TBL] [Abstract] [Full Text] [Related]
14. [
Chen J; Xu K; Li C; Tian Y; Li L; Wen B; He C; Cai H; He Y
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4064-4076. PubMed ID: 37526694
[TBL] [Abstract] [Full Text] [Related]
15. The performance of Carbohydrate Antigen 125-Thomsen-nouveau and anti-Müllerian hormone combined with CA125, Human epididymis protein 4 and Risk of Malignancy Algorithm in diagnosis for patients with Epithelial ovarian cancer.
Hou X; Liu S; Liu J; Zhou J; Liang Y; Cui L
Clin Biochem; 2023 Sep; 119():110615. PubMed ID: 37517433
[TBL] [Abstract] [Full Text] [Related]
16. Recent Insight about he4 Role in ovarian cancer Oncogenesis.
Anastasi E; Farina A; Granato T; Colaiacovo F; Pucci B; Tartaglione S; Angeloni A
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445657
[TBL] [Abstract] [Full Text] [Related]
17. An analysis of clinical characteristics and prognosis of endometrioid ovarian cancer based on the SEER database and two centers in China.
Chen S; Lu H; Jiang S; Li M; Weng H; Zhu J; Zhang T; Wang Y; Zhao W; Wu D; Shen Z; Yang Z; Zhou Y
BMC Cancer; 2023 Jul; 23(1):608. PubMed ID: 37391693
[TBL] [Abstract] [Full Text] [Related]
18. ovarian cancer Biomarkers in the COVID-19 Era.
Farina A; Colaiacovo F; Gianfrate M; Pucci B; Angeloni A; Anastasi E
Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297598
[TBL] [Abstract] [Full Text] [Related]
19. Clinical value of serum and tissue AGR2 for diagnosis and prognosis in epithelial ovarian cancer.
Yan T; Wang H; Ma X; Cao J; Tong Y; Guo L; Lu R
Biomark Med; 2023 Mar; 17(6):325-336. PubMed ID: 37284743
[No Abstract] [Full Text] [Related]
20. Mass Spectrometry-Based Proteomics of Epithelial ovarian cancers: A Clinical Perspective.
Qian L; Sun R; Xue Z; Guo T
Mol Cell Proteomics; 2023 Jul; 22(7):100578. PubMed ID: 37209814
[TBL] [Abstract] [Full Text] [Related]
[Next]
